Safety and efficacy of AAE 581 in postmenopausal women with osteoporosis.

Trial Profile

Safety and efficacy of AAE 581 in postmenopausal women with osteoporosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Balicatib (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 May 2012 Actual end date (September 2005) added as reported by ClinicalTrials.gov.
    • 07 May 2012 Actual patient number (676) added as reported by ClinicalTrials.gov.
    • 03 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top